Maximilian Kullmann

HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum‐based chemotherapy in patients with platinum‐sensitive recurrent epithelial ovarian cancer

Oliver Zivanovic, Alina Abramian, Maximilian Kullmann et al. · International Journal of Cancer · 2014 · 98 citations · Full text

Medicine, Oncology, Surgery +17

Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6

Christiane Stadler, Ursula Ellinghaus, Leyla Fischer et al. · Science Translational Medicine · 2024 · 55 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Structure–Permeability Relationship of Semipeptidic Macrocycles—Understanding and Optimizing Passive Permeability and Efflux Ratio

Antoine Le Roux, Émilie Blaise, Pierre‐Luc Boudreault et al. · Journal of Medicinal Chemistry · 2020 · 32 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance

Maximilian Kullmann, Ganna V. Kalayda, Malte Hellwig et al. · Journal of Inorganic Biochemistry · 2015 · 19 citations

Life Sciences, Biochemistry, Molecular Biology +12

Combination of two‐dimensional gel electrophoresis and a fluorescent carboxyfluorescein‐diacetate‐labeled cisplatin analogue allows the identification of intracellular cisplatin–protein adducts

Sandra Kotz, Maximilian Kullmann, Barbara Crone et al. · Electrophoresis · 2015 · 14 citations

Medicine, Oncology, Pharmacology +15